GENEWIZ offers a wide range of services to support research in oncology and genetic disorders. From the latest next generation sequencing (NGS) technologies to traditional polymorphism detection via Sanger-based services, our genomic solutions for cancer research can be used to elucidate mechanisms of cancer, drive therapeutic target discovery, enhance biomarker discovery, and stratify patients in clinical trials. Find out more about our oncology-based solutions below.
Structural Variant Detection (>1kb)
PacBio® long-read sequencing technology is optimal for the detection of large genomic rearrangements, which have been shown to drive tumor development.
We also offer....
The GENEWIZ Difference
|Next Generation Sequencing||ext. email@example.com|
|Sanger Sequencing||ext. firstname.lastname@example.org|
|Synthetic DNA Solutions||ext. email@example.com|
|Molecular Genetics||ext. firstname.lastname@example.org|
|GLP-Compliant Services||ext. email@example.com|